Electra Therapeutics, Inc.
Biotechnology company · South San Francisco, California, United States · Nasdaq: ETRA
Electra Therapeutics, Inc. is a biotechnology company headquartered in South San Francisco, California, United States. Its shares trade on Nasdaq under the ticker ETRA. It has reported private securities offerings to the US SEC, most recently $134 million sold in a notice filed in 2025.
Electra Therapeutics at a glance
What does Electra Therapeutics do?
Private fundraising reported to the SEC
1 Form D notice; the most recent reported $134.2 million sold (2025).
Frequently asked questions about Electra Therapeutics
Where is Electra Therapeutics headquartered?
Electra Therapeutics, Inc. is headquartered in South San Francisco, California, United States.
What does Electra Therapeutics do?
Electra Therapeutics, Inc. is a biotechnology company. Its SEC industry classification is Biological Products, (No Diagnostic Substances).
Is Electra Therapeutics a public company?
Yes. Electra Therapeutics, Inc. trades on Nasdaq under the ticker ETRA.
Similar companies
- Alector, Inc.South San Francisco, California, United States
- Vaxart, Inc.South San Francisco, California, United States
- Denali Therapeutics Inc.South San Francisco, California, United States
- Aligos Therapeutics, Inc.South San Francisco, California, United States
- PROFUSA, Inc.South San Francisco, California, United States
- Quince Therapeutics, Inc.South San Francisco, California, United States
- Allogene Therapeutics, Inc.South San Francisco, California, United States
- Sutro Biopharma, Inc.South San Francisco, California, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.